Recent And Upcoming FDA Advisory Committee Meetings
Executive Summary
Recent and upcoming US FDA advisory committee meetings and a summary of topics covered.
You may also be interested in...
Moderna's COVID-19 Vaccine Booster US FDA Panel Nod Driven By Pragmatism
Despite lack of enthusiasm with immunobridging study data, the panel endorsed emergency use in certain at-risk populations, in part because it would be hard to turn down the Moderna booster when an identical EUA had been issued for Pfizer/BioNTech's mRNA vaccine.
Janssen Booster Evidence Draws Questions From US FDA, But Also A Nod Towards Benefits
Agency assessors couldn’t independently verify several Janssen analyses of booster shot data and raised concerns about small samples sizes and an unvalidated immunogenicity assay.
Cash Injection Puts Quell At Forefront Of Treg Therapy
The London-based biotech is hoping to turn the dream of liver organ transplant without the need for lifelong immunosuppression into reality.